Top compounds associated with response to MTRNR2L8


Feature Type Standardized
Nominal ANOVA
mRNA Dasatinib CTRPv2 pan-cancer AAC 0.043 0.2
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.035 0.2
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.041 0.2
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC -0.09 0.2
mRNA cediranib CTRPv2 pan-cancer AAC -0.062 0.2
mRNA cimetidine CTRPv2 pan-cancer AAC -0.08 0.2
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.044 0.2
mRNA SU11274 CTRPv2 pan-cancer AAC -0.041 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.2
Download CSV